- Home
- VANI vs ATLX Comparison
VANI vs ATLX Comparison
Compare VANI & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ATLX
- Stock Information
- Founded
- VANI 1998
- ATLX 2011
- Country
- VANI United States
- ATLX Brazil
- Employees
- VANI 36
- ATLX N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- VANI Health Care
- ATLX Industrials
- Exchange
- VANI Nasdaq
- ATLX Nasdaq
- Market Cap
- VANI 75.2M
- ATLX 68.5M
- IPO Year
- VANI 2014
- ATLX N/A
- Fundamental
- Price
- VANI $1.40
- ATLX $4.05
- Analyst Decision
- VANI Strong Buy
- ATLX Strong Buy
- Analyst Count
- VANI 1
- ATLX 2
- Target Price
- VANI $4.00
- ATLX $22.25
- AVG Volume (30 Days)
- VANI 134.3K
- ATLX 246.0K
- Earning Date
- VANI 08-12-2025
- ATLX 08-08-2025
- Dividend Yield
- VANI N/A
- ATLX N/A
- EPS Growth
- VANI N/A
- ATLX N/A
- EPS
- VANI N/A
- ATLX N/A
- Revenue
- VANI N/A
- ATLX $587,122.00
- Revenue This Year
- VANI N/A
- ATLX $19,668.81
- Revenue Next Year
- VANI N/A
- ATLX $43.15
- P/E Ratio
- VANI N/A
- ATLX N/A
- Revenue Growth
- VANI N/A
- ATLX 214.46
- 52 Week Low
- VANI $0.91
- ATLX $3.54
- 52 Week High
- VANI $1.50
- ATLX $13.70
- Technical
- Relative Strength Index (RSI)
- VANI 74.26
- ATLX 52.10
- Support Level
- VANI $1.26
- ATLX $3.70
- Resistance Level
- VANI $1.30
- ATLX $4.25
- Average True Range (ATR)
- VANI 0.06
- ATLX 0.25
- MACD
- VANI 0.00
- ATLX 0.03
- Stochastic Oscillator
- VANI 69.70
- ATLX 76.92
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.